What ICD‑10‑CM code should be used for idiopathic palmar eccrine hidradenitis (and neutrophilic eccrine hidradenitis) and what is the corresponding ICD‑9‑CM cross‑walk code?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 28, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

ICD-10-CM Coding for Idiopathic Palmar Eccrine Hidradenitis and Neutrophilic Eccrine Hidradenitis

For idiopathic palmar eccrine hidradenitis (and palmoplantar eccrine hidradenitis), use ICD-10-CM code L74.8 (Other eccrine sweat disorders), with ICD-9-CM cross-walk code 705.89 (Other specified disorders of sweat glands).

Coding Rationale

The provided evidence does not contain specific ICD coding guidelines for these rare neutrophilic dermatoses. However, based on the clinical descriptions in the research literature and standard ICD-10-CM classification principles:

For Idiopathic Palmoplantar Eccrine Hidradenitis (IPPH):

  • ICD-10-CM: L74.8 - "Other eccrine sweat disorders"
  • ICD-9-CM: 705.89 - "Other specified disorders of sweat glands"

This condition is characterized by neutrophilic infiltrates around eccrine sweat glands in otherwise healthy children and young adults, typically affecting palms and soles 1, 2, 3, 4. The disorder involves the eccrine apparatus specifically and doesn't fit other more specific hidradenitis categories.

For Neutrophilic Eccrine Hidradenitis (NEH):

  • ICD-10-CM: L74.8 - "Other eccrine sweat disorders"
  • ICD-9-CM: 705.89 - "Other specified disorders of sweat glands"

NEH is a reactive neutrophilic dermatosis typically associated with malignancy or chemotherapy in adults, though idiopathic cases occur 5, 6. The histologic hallmark is dense neutrophilic infiltration around eccrine glands.

Important Coding Considerations

Do not confuse with hidradenitis suppurativa (HS), which has distinct ICD-10-CM codes:

  • L73.2 for hidradenitis suppurativa
  • This is a completely different chronic inflammatory condition affecting apocrine glands 7

Clinical documentation is critical because:

  • These are rare diagnoses requiring histopathologic confirmation
  • The distinction between idiopathic palmoplantar eccrine hidradenitis and neutrophilic eccrine hidradenitis may require documentation of associated conditions (malignancy, chemotherapy) or precipitating factors (physical activity in children)
  • ICD-10-CM code specificity utilization remains suboptimal in ambulatory settings, with only 44.6% of available codes actually used 8

For billing and documentation purposes, ensure the medical record clearly states:

  • Histopathologic confirmation of neutrophilic infiltrate around eccrine glands
  • Location (palmar, plantar, or other sites)
  • Associated conditions if present (malignancy, chemotherapy exposure)
  • Whether idiopathic or secondary

The lack of more specific ICD-10-CM codes for these rare neutrophilic dermatoses reflects their uncommon occurrence and recent clinical recognition in the literature 1, 2, 3, 4.

References

Research

[An uncommon cause of delayed walking: idiopathic palmoplantar hidradenitis].

Archives de pediatrie : organe officiel de la Societe francaise de pediatrie, 2015

Research

Idiopathic palmoplantar eccrine hidradenitis in children.

European journal of pediatrics, 2001

Research

Idiopathic palmoplantar hidradenitis.

The American Journal of dermatopathology, 1996

Research

Neutrophilic eccrine hidradenitis: a retrospective study.

International journal of dermatology, 2023

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.